India to Sudan: Cefpodoxime Export Trade Route

The India to Sudan Cefpodoxime corridor is one of India's established pharmaceutical export routes, with 144 shipments documented worth a combined $3.1M USD. The route is dominated by MEDINOK HEALTHCARE PRIVATE LIMITED, which alone accounts for roughly 42% of all export value, reflecting the consolidated nature of India's cefpodoxime manufacturing sector.

Across 33 active suppliers, the average shipment value stands at $21.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with cefpodoxime's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 18.6%, placing it at rank #6 among India's top cefpodoxime export destinations globally.

On the import side, key buyers of Indian cefpodoxime in Sudan include AMDWYR FOR IMPORT AND EXPORT, MODERM INTERNATIONAL, TO THE DIRECTOR OF and 47 others. AMDWYR FOR IMPORT AND EXPORT is the single largest importer with 4 shipments valued at $857.9K USD.

India's cefpodoxime exports to Sudan are driven primarily by a handful of large-scale manufacturers. MEDINOK HEALTHCARE PRIVATE LIMITED with 7 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 33 active exporters signals a competitive but concentrated market — buyers in Sudan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MEDINOK HEALTHCARE PRIVATE LIMITED, SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI, ARISTO PHARMACEUTICALS PRIVATE LIMITED — together account for 65% of total trade value on this route. The average shipment value of $21.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as cefpodoxime proxetil 200mg and tablets doxim cefpodoxime proxetil tablets usp 200 mg batch no adtc23001 to adtc23005 manufacturing date- aug 2023 / exp date, suggesting that buyers in Sudan tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, AMDWYR FOR IMPORT AND EXPORT is the largest importer with 4 shipments worth $857.9K USD — representing 28% of all cefpodoxime imports from India on this route. A total of 50 buyers are active on this corridor.